Literature DB >> 15668280

Development of axillary surgery in breast cancer.

A Luini1, G Gatti, B Ballardini, S Zurrida, V Galimberti, P Veronesi, A R Vento, S Monti, G Viale, G Paganelli, U Veronesi.   

Abstract

Axillary surgery is a critical part of the treatment of breast carcinoma: its importance is related to the staging of disease, prescription of adjuvant therapy and prognosis. For years, complete axillary dissection has remained the standard approach to breast cancer lymphatic staging; its value is still high, but the development of sentinel-node biopsy has significantly changed the indication of the procedure. We discuss the evolution of axillary surgery in breast cancer.

Entities:  

Mesh：

Year:  2005        PMID： 15668280     DOI： 10.1093/annonc/mdi060

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


  15 in total

1.  Comparison of mastoscopic and conventional axillary lymph node dissection in breast cancer: long-term results from a randomized, multicenter trial.

Authors:  Chengyu Luo; Wenbin Guo; Jie Yang; Qiuru Sun; Wei Wei; Suhua Wu; Shubing Fang; Qingliang Zeng; Zhensheng Zhao; Fanjie Meng; Xuandong Huang; Xianlan Zhang; Ruihua Li; Xiufeng Ma; Chaoying Luo; Yun Yang
Journal:  Mayo Clin Proc       Date:  2012-11-09       Impact factor: 7.616

2.  Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?

Authors:  C H Yip; N A Taib; G H Tan; K L Ng; B K Yoong; W Y Choo
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

3.  Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors.

Authors:  Guo-Yan Liu; Qi Luo; Bin Xiong; Chao Pan; Ping Yin; Hong-Feng Liao; Wei-Chun Zhuang; Hong-Zhi Gao
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

4.  Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?

Authors:  Laura H Rosenberger; Yi Ren; Samantha M Thomas; Rachel A Greenup; Oluwadamilola M Fayanju; E Shelley Hwang; Jennifer K Plichta
Journal:  Breast Cancer Res Treat       Date:  2019-11-18       Impact factor: 4.872

5.  Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green.

Authors:  Yoshiaki Shinden; Hiroki Ueo; Taro Tobo; Ayako Gamachi; Mitsuaki Utou; Hisateru Komatsu; Sho Nambara; Tomoko Saito; Masami Ueda; Hidenari Hirata; Shotaro Sakimura; Yuki Takano; Ryutaro Uchi; Junji Kurashige; Sayuri Akiyoshi; Tomohiro Iguchi; Hidetoshi Eguchi; Keishi Sugimachi; Yoko Kubota; Yuichiro Kai; Kenji Shibuta; Yuko Kijima; Heiji Yoshinaka; Shoji Natsugoe; Masaki Mori; Yoshihiko Maehara; Masayo Sakabe; Mako Kamiya; John W Kakareka; Thomas J Pohida; Peter L Choyke; Hisataka Kobayashi; Hiroaki Ueo; Yasuteru Urano; Koshi Mimori
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

Review 6.  Sentinel Lymph Node Biopsy in Breast Cancer.

Authors:  Vijaya V Mysorekar
Journal:  World J Oncol       Date:  2010-02-01

7.  Nomograms for preoperative prediction of axillary nodal status in breast cancer.

Authors:  L Dihge; P-O Bendahl; L Rydén
Journal:  Br J Surg       Date:  2017-07-18       Impact factor: 6.939

8.  Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.

Authors:  Shabaz Majid; Lisa Rydén; Jonas Manjer
Journal:  World J Surg Oncol       Date:  2018-03-12       Impact factor: 2.754

9.  Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.

Authors:  Hanchu Xiong; Zihan Chen; Ling Xu; Cong Chen; Qingshuang Fu; Rongyue Teng; Jida Chen; Shuduo Xie; Linbo Wang; Xiao-Fang Yu; Jichun Zhou
Journal:  Cancer Control       Date:  2020 Apr-Jun       Impact factor: 3.302

10.  Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer.

Authors:  Yun Liu; Massimo Bellomi; Giovanna Gatti; Xuejun Ping
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.